# Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cancer

> **NCT07050563** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai Municipal Hospital of Traditional Chinese Medicine** · enrollment: 316 (estimated)

## Conditions studied

- Cancer
- Cancer Symptom Clusters

## Interventions

- **DRUG:** Compound Ciwujia Granules
- **DRUG:** Placebo granules
- **COMBINATION_PRODUCT:** Standard treatment protocol for ovarian cancer combined with psychological intervention.

## Key facts

- **NCT ID:** NCT07050563
- **Lead sponsor:** Shanghai Municipal Hospital of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-06
- **Primary completion:** 2028-09-01
- **Final completion:** 2028-11-30
- **Target enrollment:** 316 (ESTIMATED)
- **Last updated:** 2025-09-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07050563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07050563, "Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07050563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*